Cell & Gene CMO Sourcing Center
The number of clinical trials in cell and gene therapy has exploded – estimates are of over 1,000 clinical trials ongoing globally.
Many of these new therapeutic approaches require the production of viral vectors. Viral vector manufacturing today is cumbersome, and the yields are poor. If you are a startup biotech in need of viral vectors today, getting into capacity could be an issue. Complicating matters, cell and gene therapies require a certain proximity to patient and process/treatment centers, which will keep most U.S.-based drug and therapy developers looking for domestic (and regional) partners.
How can we help?
Looking for help with your Cell & Gene project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.
Cell & Gene CMOs
Through a series of integrated science platforms, Aldevron offers nucleic acid, protein, and antibody services that enable pharmaceutical companies and research institutes to do groundbreaking science. By supplying what they need, when they need it, with expert support at every stage of development and production, we help our clients open up their laboratories for ground-breaking science and breakthrough discoveries.
Andelyn Biosciences is a pioneering gene therapy organization born out of Nationwide Children's Hospital, where the first FDA-approved systemic gene therapy was discovered.
With more than 15 years of experience in AAV vector manufacturing, Andelyn is a full-spectrum CDMO. We bring scalability, capacity, efficiency and expert resources to manufacturing matrices, all to advance the development of viral vector-based therapeutics.
Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.
CCRM provides innovative CDMO services to enable the development and commercialization of cell and gene therapies and regenerative medicine technologies. With our customer-focused approach customized to each client, we provide process development and cGMP manufacturing services tailored to our clients’ timelines, financing, ambitions, and needs.
Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation.
Evonik serves as a global development partner and solutions provider to biotechnology companies to help them transform complexity into value. We bring together a broad, versatile range of core competencies, a trusted global network of sites, and strong technical expertise to support you in the development, scale-up, and manufacturing of biopharmaceutical products.
IDT Biologika is a contract development and manufacturing organization offering services for partners committed to the development and marketing of therapeutic and prophylactic vaccines and other biological products. Focused on viral live vaccines and other biopharmaceuticals such as recombinant proteins and monoclonal antibodies, IDT Biologika utilizes state-of-the-art facilities and offers many years of experience in the development of production processes and commercial manufacturing.
Kindeva Drug Delivery
Headquartered outside St. Paul, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microstructured transdermal systems (microsystems), and connected drug delivery.
Lonza Pharma & Biotech
Lonza is one of the world’s most renowned companies for contract development and manufacturing, Lonza Pharma & Biotech is recognized for our reliable, high-quality services, our global capacity, our innovative technology platforms, and our extensive experience.
Ology Bioservices® is now part of Resilience (National Resilience, Inc.). Resilience is a first-of-its-kind manufacturing and technology company offering a network of high-tech, end-to-end manufacturing solutions including production of cell and gene therapies, viral vectors, oncolytic viruses and vaccines. Resilience offers the highest quality and regulatory capabilities with support from IND through Licensure, along with flexible and adaptive facilities to serve partners of all sizes.
Patheon, by Thermo Fisher Scientific
Cell & Gene Supply Chain
With a global infrastructure that enables customers to seamlessly conduct cell therapy clinical trials across multiple geographies, Patheon, by Thermo Fisher Scientific is provides patients around the world with access to life changing therapies.
Rentschler Biopharma, a global leading CDMO, is your outsourcing partner of choice for bioprocess development and cGMP manufacturing. With almost 50 years of proven scientific expertise, we guarantee best-fit solutions for clinical and commercial supply. Our commitment is reflected in our exceptional client-oriented project management and regulatory support. We are headquartered in Laupheim, Germany, with a second site in Milford, MA, USA.
Sharp is a global leader in contract packaging and clinical trial supply services to the pharmaceutical and biotechnology industries. Operating from eight state-of-the art facilities across the United States and Europe, Sharp works collaboratively with pharmaceutical and biotechnology clients across the world to create unique commercial and clinical solutions for even the most complex drug products.
West is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Pharmaceutical, biotechnology, generic and medical device companies trust West and our ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. We share their commitment to improving health for patients worldwide.